Daniel Menold, Vice President, Finance at CymaBay Therapeutics, Inc. (CBAY), sold 32,994 shares at $21.98 ($725K) on 2023-12-15, disclosed to the SEC on 2023-12-15.
Scheduled sale ($725k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.98 | 10,000 | $220K | 30.3% |
| 2 | $21.99 | 11,497 | $253K | 34.9% |
| 3 | $21.99 | 11,497 | $253K | 34.9% |
| Total | $21.99 avg | 32,994 | $725K | 100% |
| Filing → |
| CBAY | SELL | 2018-08-31 | $65K | — | Filing → |